Overview
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 8
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 10, 2012 | Cardiosolutions Receives $8M Minority Investment from Sorin | Cardiosolutions, Inc., a West Bridgewater, MA-based developer of a percutaneous system to treat patients with moderate to severe mitral valve regurgitation, has received an $8m minority investment. The funding was provided by Sorin Group (R... |
| Sep 8, 2011 | Cardiosolutions raises $3.3M | Funding Roundup | Cardiosolutions Inc. landed about half of what it hopes will amount to a $6.5 million fundraising round, pulling in $3.3 million from eight un-named investors, according to a regulatory filing. The Stoughton, Mass.-based company is a spinou... |
| Feb 9, 2010 | STD Med expands in West Bridgewater | STD Med Inc. is expanding its footprint outside of its Stoughton, Mass., base with the acquisition of a 32,000-square-foot facility in West Bridgewater. The contract manufacturer said it will build a clean room facility in the space and hir... |
| Jan 26, 2010 | Medical device makers drum up $2.5 million in December equity, debt sales | Five medical device makers based in New England together raised more than $2.5 million in debt and equity sales, according to filings with the Securities and Exchange Commission. BioBehavioral Diagnostics Co., Cardiosolutions Inc., Echo The... |
| Dec 31, 2007 | Life sciences briefing: Monday, Dec. 31, 2007 | PowerVision pulls in $20M for intraocular lenses — Belmont, Calif.-based PowerVision, a device company developing implantable intraocular lenses, raised $20 million in a second funding round, VentureWire reports. Investors included Advanced... |
| Nov 27, 2007 | Evalve pulls in $60M, heating up heart-valve implant race | Evalve, a Menlo Park, Calif., developer of minimally invasive heart-valve repair implants, raised $60 million in a fourth funding round. Evalve’s device is designed to replace risky open-heart surgery for patients whose mitral valve, which ... |
| Sep 26, 2007 | Life sciences briefing: Wednesday, Sept. 26, 2007 | Featured companies: Ablynx, Cardiosolutions, Carigent Thereapeutics, Elusys, Genome Corp., GlobeImmune, Novazone, Targanta Therapeutics, Waterfront Media UPDATED at 5:45am on 9/27/07 GlobeImmune raises $41M for immune-system therapies — Glo... |
Reviews 0
FAQ about Cardiosolutions
When was Cardiosolutions founded?
Cardiosolutions was founded in 2011.
How much funding has Cardiosolutions raised?
Cardiosolutions has raised $8M in total across 1 funding round.
What has the press written about Cardiosolutions?
Parsers VC has collected 8 articles mentioning Cardiosolutions, among them “Cardiosolutions Receives $8M Minority Investment from Sorin” (Jul 10, 2012) and “Cardiosolutions raises $3.3M | Funding Roundup” (Sep 8, 2011).
Is Cardiosolutions still active?
Yes, Cardiosolutions is active; its latest activity on Parsers VC dates from Jul 11, 2012.